近日,春立医疗(688236.SH,股价14.65元,市值56.19亿元)发布2024年年报,公司实现营业收入8.06亿元,同比减少33.32%,归属于上市公司股东的净利润为1.25亿元,同比减少55.01%。 《每日经济新闻》记者注意到,自2021年骨科高值耗材国家集采以来,公司净利润已连续三个年度下降,而去年是春立医疗上市以来首次出现收入、利润“双降”,净利润降幅高达55.01%。对于刚刚...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.